Literature DB >> 31276202

Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).

Joyce Y Huang1,2, Tricia L Larose3,4, Hung N Luu1,2, Renwei Wang1, Anouar Fanidi3,5, Karine Alcala3, Victoria L Stevens6, Stephanie J Weinstein7, Demetrius Albanes7, Neil E Caporaso7, Mark P Purdue7, Regina G Ziegler7, Neal D Freedman7, Qing Lan7, Ross L Prentice8, Mary Pettinger8, Cynthia A Thomson9, Qiuyin Cai10, Jie Wu10, William J Blot10, Xiao-Ou Shu10, Wei Zheng10, Alan A Arslan11, Anne Zeleniuch-Jacquotte12, Loïc Le Marchand13, Lynn R Wilkens13, Christopher A Haiman14, Xuehong Zhang15, Meir J Stampfer15,16,17, Jiali Han18, Graham G Giles19,20, Allison M Hodge19,20, Gianluca Severi19,21,22, Mikael Johansson23, Kjell Grankvist24, Arnulf Langhammer25, Kristian Hveem4,25, Yong-Bing Xiang26,27, Hong-Lan Li27, Yu-Tang Gao27, Kala Visvanathan28, Per M Ueland29,30, Øivind Midttun31, Arve Ulvi31, Julie E Buring32,33, I-Min Lee32,33, Howard D Sesso16,32,33, J Michael Gaziano16,33,34, Jonas Manjer35, Caroline Relton36, Woon-Puay Koh37,38, Paul Brennan3, Mattias Johansson3, Jian-Min Yuan1,2.   

Abstract

Cell-mediated immune suppression may play an important role in lung carcinogenesis. We investigated the associations for circulating levels of tryptophan, kynurenine, kynurenine:tryptophan ratio (KTR), quinolinic acid (QA) and neopterin as markers of immune regulation and inflammation with lung cancer risk in 5,364 smoking-matched case-control pairs from 20 prospective cohorts included in the international Lung Cancer Cohort Consortium. All biomarkers were quantified by mass spectrometry-based methods in serum/plasma samples collected on average 6 years before lung cancer diagnosis. Odds ratios (ORs) and 95% confidence intervals (CIs) for lung cancer associated with individual biomarkers were calculated using conditional logistic regression with adjustment for circulating cotinine. Compared to the lowest quintile, the highest quintiles of kynurenine, KTR, QA and neopterin were associated with a 20-30% higher risk, and tryptophan with a 15% lower risk of lung cancer (all ptrend < 0.05). The strongest associations were seen for current smokers, where the adjusted ORs (95% CIs) of lung cancer for the highest quintile of KTR, QA and neopterin were 1.42 (1.15-1.75), 1.42 (1.14-1.76) and 1.45 (1.13-1.86), respectively. A stronger association was also seen for KTR and QA with risk of lung squamous cell carcinoma followed by adenocarcinoma, and for lung cancer diagnosed within the first 2 years after blood draw. This study demonstrated that components of the tryptophan-kynurenine pathway with immunomodulatory effects are associated with risk of lung cancer overall, especially for current smokers. Further research is needed to evaluate the role of these biomarkers in lung carcinogenesis and progression.
© 2019 UICC.

Entities:  

Keywords:  kynurenine; lung cancer; neopterin; quinolinic acid; tryptophan

Mesh:

Substances:

Year:  2019        PMID: 31276202      PMCID: PMC6960354          DOI: 10.1002/ijc.32555

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  41 in total

1.  An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells.

Authors:  Joshua D Mezrich; John H Fechner; Xiaoji Zhang; Brian P Johnson; William J Burlingham; Christopher A Bradfield
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

2.  IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.

Authors:  V Shankaran; H Ikeda; A T Bruce; J M White; P E Swanson; L J Old; R D Schreiber
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

3.  High-throughput, low-volume, multianalyte quantification of plasma metabolites related to one-carbon metabolism using HPLC-MS/MS.

Authors:  Øivind Midttun; Gry Kvalheim; Per Magne Ueland
Journal:  Anal Bioanal Chem       Date:  2012-12-13       Impact factor: 4.142

4.  Serum cotinine level as predictor of lung cancer risk.

Authors:  Paolo Boffetta; Sarah Clark; Min Shen; Randi Gislefoss; Richard Peto; Aage Andersen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-06       Impact factor: 4.254

5.  Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.

Authors:  Sharon R Pine; Leah E Mechanic; Lindsey Enewold; Anil K Chaturvedi; Hormuzd A Katki; Yun-Ling Zheng; Elise D Bowman; Eric A Engels; Neil E Caporaso; Curtis C Harris
Journal:  J Natl Cancer Inst       Date:  2011-06-17       Impact factor: 13.506

6.  Vitamin B6 status and interferon-γ-mediated immune activation in primary hyperparathyroidism.

Authors:  M H E Christensen; E K R Pedersen; Y Nordbø; J E Varhaug; Ø Midttun; P M Ueland; O K Nygård; G Mellgren; E A Lien
Journal:  J Intern Med       Date:  2012-08-05       Impact factor: 8.989

Review 7.  Regulation of interferon-gamma during innate and adaptive immune responses.

Authors:  Jamie R Schoenborn; Christopher B Wilson
Journal:  Adv Immunol       Date:  2007       Impact factor: 3.543

Review 8.  IDO expression by dendritic cells: tolerance and tryptophan catabolism.

Authors:  Andrew L Mellor; David H Munn
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

9.  Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men.

Authors:  Mara M Epstein; Elizabeth Crabb Breen; Larry Magpantay; Roger Detels; Lauren Lepone; Sudhir Penugonda; Jay H Bream; Lisa Paula Jacobson; Otoniel Martínez-Maza; Brenda M Birmann
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-27       Impact factor: 4.254

10.  Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

Authors:  Guido Frumento; Rita Rotondo; Michela Tonetti; Gianluca Damonte; Umberto Benatti; Giovanni Battista Ferrara
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

View more
  9 in total

1.  Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer.

Authors:  Martina Mandarano; Elena Orecchini; Guido Bellezza; Jacopo Vannucci; Vienna Ludovini; Sara Baglivo; Francesca Romana Tofanetti; Rita Chiari; Elisabetta Loreti; Francesco Puma; Angelo Sidoni; Maria Laura Belladonna
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

2.  Untargeted Urinary Metabolomics and Children's Exposure to Secondhand Smoke: The Influence of Individual Differences.

Authors:  Huiwei Zhu; Abu S Abdullah; Jingyi He; Jianxiong Xi; Yimeng Mao; Yitian Feng; Qianyi Xiao; Pinpin Zheng
Journal:  Int J Environ Res Public Health       Date:  2021-01-15       Impact factor: 3.390

3.  Dynamic change of IDO1 activity predicts survival in patients with unresectable stage III NSCLC and chemoradiotherapy.

Authors:  Linfang Wu; Daquan Wang; Yanhua Chen; Mingmin Qian; Xin Xu; Tao Zhang; Nan Bi; Luhua Wang
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

4.  Assessment of Specific Tumoral Markers, Inflammatory Status, and Vitamin D Metabolism before and after the First Chemotherapy Cycle in Patients with Lung Cancer.

Authors:  Andreea Crintea; Cristina Drugan; Anne-Marie Constantin; Iulia Lupan; Zsolt Fekete; Ciprian Nicolae Silaghi; Alexandra Mărioara Crăciun
Journal:  Biology (Basel)       Date:  2022-07-08

5.  Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19.

Authors:  Céline Occelli; Jean-Marie Guigonis; Sabine Lindenthal; Alexandre Cagnard; Fanny Graslin; Vesna Brglez; Barbara Seitz-Polski; Jean Dellamonica; Jacques Levraut; Thierry Pourcher
Journal:  Front Med (Lausanne)       Date:  2022-09-29

Review 6.  Not Only Immune Escape-The Confusing Role of the TRP Metabolic Pathway in Carcinogenesis.

Authors:  Iwona Kwiatkowska; Justyna Magdalena Hermanowicz; Alicja Przybyszewska-Podstawka; Dariusz Pawlak
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

7.  Persistent elevation of plasma vitamin B12 is strongly associated with solid cancer.

Authors:  Valentin Lacombe; Floris Chabrun; Carole Lacout; Alaa Ghali; Olivier Capitain; Anne Patsouris; Christian Lavigne; Geoffrey Urbanski
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

Review 8.  Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer.

Authors:  Lukas Lanser; Patricia Kink; Eva Maria Egger; Wolfgang Willenbacher; Dietmar Fuchs; Guenter Weiss; Katharina Kurz
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

9.  Pre-diagnosis neutrophil-to-lymphocyte ratio and mortality in individuals who develop lung cancer.

Authors:  Carmen J Marsit; Jennifer A Doherty; Laurie Grieshober; Stefan Graw; Matt J Barnett; Gary E Goodman; Chu Chen; Devin C Koestler
Journal:  Cancer Causes Control       Date:  2021-07-08       Impact factor: 2.506

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.